The sleep trial’s null findings followed a controlled pre-session routine. Food timing, caffeine and alcohol restrictions, and prior-night sleep requirements were part of the experimental conditions.
The preparation was specified
Participants were instructed to avoid alcohol and caffeine for at least twenty-four hours before visits. Those reporting fewer than six hours of sleep the preceding night were excluded. After at least eight hours of fasting, participants had a light standardized meal two hours before the experiment.
CBD or placebo was administered thirty minutes before an eight-hour polysomnographic recording. These details help define the context of the observed overnight comparison.
A controlled routine is not every use scenario
The study did not separately vary meal composition, caffeine exposure or sleep deprivation to estimate their interactions with CBD. Its result cannot establish that the same outcomes would occur after a heavy meal, stimulant use or substantial sleep loss. Those alternatives were not randomized conditions here.
Interpret the null within the protocol
A single 300 mg CBD dose did not significantly alter the conventional sleep measures in these healthy adults. That finding supports a statement about the tested routine, not a guarantee across all consumer circumstances. The protocol also does not provide a safe redosing interval, a treatment recommendation for insomnia or a comprehensive assessment of next-day driving ability.
Related reading: limits on proposed CBD mechanisms.
Research cited
Linares and colleagues (2018). No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. DOI: 10.3389/fphar.2018.00315.
Leave a Reply